Oxford Nanopore Technologies plc (ONTTF)
OTCMKTS
· Delayed Price · Currency is USD
1.730
-0.001 (-0.06%)
May 28, 2025, 10:02 AM EDT
ONTTF Revenue
In the year 2024, Oxford Nanopore Technologies had annual revenue of 183.19M GBP with 7.97% growth. Oxford Nanopore Technologies had revenue of 99.11M in the half year ending December 31, 2024, with 29.97% growth.
Revenue
183.19M GBP
Revenue Growth
+7.97%
P/S Ratio
6.97
Revenue / Employee
132.55K GBP
Employees
1,382
Market Cap
1.60B USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 183.19M | 13.52M | 7.97% |
Dec 31, 2023 | 169.67M | -28.94M | -14.57% |
Dec 31, 2022 | 198.60M | 64.94M | 48.59% |
Dec 31, 2021 | 133.66M | 19.80M | 17.39% |
Dec 31, 2020 | 113.86M | 61.80M | 118.70% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Oxford Nanopore Technologies News
- 6 weeks ago - Breakthrough algorithm enables partially phased, near telomere-to-telomere assembly using standard Oxford Nanopore Simplex reads - Business Wire
- 6 weeks ago - Oxford Nanopore Expands Compatible Products Programme and Strengthens Multi-Omics Ecosystem - Business Wire
- 3 months ago - Oxford Nanopore Technologies plc (ONTTF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - UK Stock Market News: Greggs, Beazley, Oxford Nanopore - The Armchair Trader
- 4 months ago - UK Stock Market News: PageGroup, Oxford Nanopore, Entain - The Armchair Trader
- 6 months ago - Oxford Nanopore and UK Biobank to create world's first epigenetic dataset targeting the causes of cancer, dementia, complex disease - Business Wire
- 7 months ago - UK health agencies join with Oxford Nanopore to speed up pathogen screening - Financial Times
- 7 months ago - Oxford Nanopore Announces Landmark UK Government Partnership to Advance Genomics-Driven Healthcare Innovation in the UK - Business Wire